Should you buy SBFM stock?

Last updated:

Based on market data through , StockInvest.us rates Sunshine Biopharma, Inc. (SBFM) as a Strong Sell Candidate with a technical score of -5.37 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Up 4.27%
  • 3-month trend forecast Down 76.37%
  • Strong Sell Candidate -5.37
AI Analysis AI Analysis of SBFM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add SBFM to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Sunshine Biopharma, Inc. stock price down 0.81% on Monday
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 31, 2026 Gain 4.27%

The Sunshine Biopharma, Inc. stock price fell by -0.81% on the last day (Monday, 10th Aug 2026) from $1.23 to $1.22. During the last trading day the stock fluctuated 2.93% from a day low at $1.20 to a day high of $1.23. The price has fallen in 5 of the last 10 days and is down by -20.26% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 million shares and in total, 333 thousand shares were bought and sold for approximately $406.48 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.35 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SBFM Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 4.27%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sunshine Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.26 and $1.77. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock

Sunshine Biopharma, Inc. finds support from accumulated volume at $1.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0350 between high and low, or 2.93%. For the last week the stock has had daily average volatility of 17.58%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SBFM) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Sunshine Biopharma, Inc. to open at $1.22, and during the day (based on 14 day Average True Range), to move between $1.11 and $1.33, which gives a possible trading interval of +/-$0.221 (+/-19.88%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 19.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.23 (0.82%) than the support at $1.17 (4.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sunshine Biopharma, Inc. stock A Buy?

Sunshine Biopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.368 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $1.22 ( 0.410%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

SBFM Performance

Trading levels for SBFM

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.25 2.46%
R2 1.24 1.36%
R1 1.23 0.686%
Price 1.22
S1 1.20 -1.51%
S2 1.19 -2.18%
S3 1.18 -3.28%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.33 9.02%
R2 1.31 7.38%
R1 1.23 0.82%
Price 1.22
S1 1.17 -4.10%
S2 0 -
S3 0 -

FAQ

What is the symbol for Sunshine Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for Sunshine Biopharma, Inc. is SBFM and it is traded on the PINK (Pink Sheets).

Should I buy or sell Sunshine Biopharma, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Sunshine Biopharma, Inc. (SBFM) as a Strong Sell Candidate with a technical score of -5.37 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jul 31, 2026, the price has risen 4.27%. The current 3-month trend forecast projects a fall of 76.37%.

How to buy Sunshine Biopharma, Inc. Stock?
Sunshine Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sunshine Biopharma, Inc. Stock.

What's the current price of Sunshine Biopharma, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Sunshine Biopharma, Inc. (SBFM) share was $1.22.

What is the 52-week high and low for Sunshine Biopharma, Inc. Stock?
The 52-week high for Sunshine Biopharma, Inc. Stock is $24.30 and the 52-week low is $1.11.

What is the market capitalization of Sunshine Biopharma, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Sunshine Biopharma, Inc. is 2.902M.

When is the next earnings date for Sunshine Biopharma, Inc.?
The upcoming earnings date for Sunshine Biopharma, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT SUNSHINE BIOPHARMA, INC.
Sunshine Biopharma
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast c...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE